According to a study carried out by Dr. Donald Landry and his team at the University of Columbia, an enzyme can break the molecules of cocaine and crack in the blood and thus reduce the relationship with the drug that the toxicómanos have.
The enzyme is a catalytic monoclonal antibody (AMK). The antibody is because it is associated with a specific antigen and, if called catalytic, is because it divides the molecule into two inert products. The clinical advantage is to act quickly against other products. For example, the classic anti-drug called desipramine does not affect until a few weeks.
The product will not be marketed this year and when it is marketed it will be taken by injection.